lunes, 24 de junio de 2024

‘We’re failing right now’ in type 2 diabetes, FDA chief says Elizabeth Cooney By Elizabeth Cooney June 21, 2024

https://www.statnews.com/2024/06/21/robert-califf-diabetes-type-2-chronic-disease/?utm_campaign=morning_rounds&utm_medium=email&_hsenc=p2ANqtz--Clmx5K8Xc7JxuvVCaZAh9CeU2s89QYAqH5MVEaPCPZWm83zb00hat6v1FZztJ7TQ8VmmYGt0tf_TLAxEslHRizLzAtA&_hsmi=312829735&utm_content=312829735&utm_source=hs_email ONE NOTABLE QUOTE 'We’re failing right now.' That’s FDA Commissioner Robert Califf, speaking about a lack of progress on type 2 diabetes on Friday at the American Diabetes Association conference. He believes that providers are underutilizing options like bariatric surgery and the new obesity drugs for treating an “epidemic” of type 2 diabetes. Califf expressed more hope for the research happening in type 1 diabetes. Read more on Califf’s comments from STAT’s Liz Cooney. Here are the dozens of weight loss drugs in development to catch a booming market Elaine Chen Allison DeAngelis J. Emory Parker By Elaine Chen , Allison DeAngelis , and J. Emory Parker https://www.statnews.com/2023/09/12/new-weight-loss-drug-tracker-novo-nordisk-eli-lilly/?utm_campaign=morning_rounds&utm_medium=email&_hsenc=p2ANqtz-8UKrY8vTzLwdqejKjOmNRcEVV8HI26znkm4qq43-jxvqcCZ8SoqEz_CC-hB2MeaMAunJonuUS47PD4mXQHMm4MUhZ5BQ&_hsmi=312829735&utm_content=312829735&utm_source=hs_email Sept. 12, 2023 What do new weight loss drugs mean for the future of bariatric surgery? By Simar BajajAug. 28, 2023 https://www.statnews.com/2023/08/28/obesity-bariatric-surgery-new-weight-loss-drugs/?utm_campaign=morning_rounds&utm_medium=email&_hsenc=p2ANqtz--mMt9BaJ2wdm7yGsY5DDpsXbPbDoBJnptcZkfQOhkAFcbzECEH5vg9Guf0SIcHMOc2NeVtZtrxQuhqWDx43peWSGiuNw&_hsmi=312829735&utm_content=312829735&utm_source=hs_email

No hay comentarios:

Publicar un comentario